603259 WuXi AppTec
- 56.12
- -0.60-1.06%
WuXi AppTec News
Yao Ming Kangde: Announcement on cancellation of shares repurchased for the third time in 2024 and share changes
Announcement on subscribing to private equity shares
Announcement on the Company\'s Guarantee for Wholly-owned Subsidiaries
Announcement on the completion of the issuance of 0.5 billion US dollars of zero-interest guaranteed convertible bonds due in 2025
Announcement on the listing of 0.5 billion USD zero-interest guaranteed convertible bonds due in 2025 on the Hong Kong Stock Exchange Limited
Voluntary Announcement on WuXi ATU Media Coverage
Announcement on the proposed issuance of 0.5 billion US dollars zero-interest guaranteed convertible bonds due in 2025
Announcement on the shareholding status of the top ten shareholders and the top ten shareholders with unlimited sales conditions in the matter of repurchasing A-shares
2024 Annual Plan to Improve Efficiency and Return to Profit Action Plan.
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders, the 2nd A-Share Category Shareholders' Meeting in 2024 and the 2nd H-Share Category Shareholders' Meeting in 2024.
Legal Opinion on the 2023 Annual Shareholders Meeting, 2024 Second A-Share Category Shareholders Meeting, and 2024 Second H-Share Category Shareholders Meeting of Wuxi AppTec Co., Ltd.
Wuxi AppTec New Drug Development Co., Ltd. Articles of Association (revised in 2024).
Board of Directors Meeting Rules of Wuxi Apptec for New Drug Development Co., Ltd. (Revised in 2024)
Announcement on subscribing to private equity shares
Notice on holding the 2023 Annual General Meeting of Shareholders, the 2nd Class A Shareholders' Meeting in 2024, and the 2nd Class H Shareholders' Meeting in 2024
Meeting materials for the 2023 Annual General Meeting of Shareholders, the 2024 Second Class A Shareholders' Meeting, and the 2024 Second Class H Shareholders' Meeting
Wuxi Pharmaceutical Kangde New Drug Development Co., Ltd. 2024 H Share Incentive Trust Plan (Draft)
Notice on changing the registered capital of the company and amending the company's articles of association
Report of the Audit Committee of the Board of Directors on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties
Notice on amending the company's articles of association
Analysis
Price Target
No Data
No Data